Start Over

The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases.

Authors :: Wu X
Sun M
Yang Z
Lu C
Wang Q
Wang H
Deng C
Liu Y
Yang Y
Source :: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Aug 19; Vol. 9, pp. 686548. Date of Electronic Publication: 2021 Aug 19 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Chemokine is a structure-related protein with a relatively small molecular weight, which can target cells to chemotaxis and promote inflammatory response. Inflammation plays an important role in aging. C-C chemokine receptor 9 (CCR9) and its ligand C-C chemokine ligand 25 (CCL25) are involved in the regulating the occurrence and development of various diseases, which has become a research hotspot. Early research analysis of CCR9-deficient mouse models also confirmed various physiological functions of this chemokine in inflammatory responses. Moreover, CCR9/CCL25 has been shown to play an important role in a variety of inflammation-related diseases, such as cardiovascular disease (CVD), rheumatoid arthritis, hepatitis, inflammatory bowel disease, asthma, etc. Therefore, the purpose of this review gives an overview of the recent advances in understanding the roles of CCR9/CCL25 in inflammation and inflammation-associated diseases, which will contribute to the design of future experimental studies on the potential of CCR9/CCL25 and advance the research of CCR9/CCL25 as pharmacological inflammatory targets.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Wu, Sun, Yang, Lu, Wang, Wang, Deng, Liu and Yang.)